Articles  |   July 2018
SEE Question
Article Information
Airway Management / Ambulatory Anesthesia / Neuromuscular Diseases and Drugs / Pharmacology / Articles
Articles   |   July 2018
SEE Question
ASA Monitor 7 2018, Vol.82, 43.
ASA Monitor 7 2018, Vol.82, 43.
The Society for Ambulatory Anesthesia (SAMBA) recently released a position statement regarding the availability of succinylcholine and dantrolene in ambulatory and office-based surgery facilities that do not provide general anesthesia with inhalational agents. Which of the following is least consistent with their recommendations?
Class B ambulatory and office-based surgery facilities provide oral, parenteral, or intravenous (I.V.) sedation and analgesic or dissociative drugs for minimally or moderately invasive surgical procedures. They do not provide general anesthesia with inhalational agents. These facilities are not required to stock dantrolene if patients are not exposed to known MH triggers. Thus, they often do not stock succinylcholine, as its presence could be interpreted as meaning that dantrolene must be available.
First Page Preview
First page PDF preview
First page PDF preview ×
View Large
0 Comments
Submit a Comment
Submit A Comment

Contributors must reveal any conflict of interest. Comments are moderated.

Name
Affiliation & Institution
I have a potential conflict of interest
Comment Title
Comment


This feature is available to Subscribers Only
ASA Member Login or Create an Account ×